4. CAR-T Cell Therapy: Engineering Immune Defenders
CAR-T cell therapy is at the forefront of personalized cancer treatment. By genetically engineering a patient’s own T cells to specifically target and destroy cancer cells, this approach has led to remarkable clinical successes. Recent FDA approvals for certain leukemias and lymphomas underscore its game-changing potential. Ongoing research is now expanding CAR-T applications to solid tumors and even some autoimmune diseases, broadening its impact. To delve deeper into how CAR-T therapy is reshaping oncology, visit Cancer.gov.